Plasminogen Activator Inhibitor Type-1 Tag Single-Nucleotide Polymorphisms in Patients with Diabetes Mellitus Type 2 and Diabetic Retinopathy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Eye Research

• Publication date

  2017-02-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/02713683.2016.1276197PMID 28632032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between Polymorphisms and Haplotypes in AKR1B1 and Diabetes Type 2 leading to Complications

  2015cited by this paper
• Linkage Analysis of Genomic Regions Contributing to the Expression of Type 1 Diabetes Microvascular Complications and Interaction with HLA

  2015cited by this paper
• Effect of angiotensin-converting enzyme tag single nucleotide polymorphisms on the outcome of patients with traumatic brain injury

  2015cited by this paper
• The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy

  2014cited by this paper
• Genetics of Diabetic Retinopathy

  2014cited by this paper
• Epigenetic Mechanisms in the Pathogenesis of Diabetic Retinopathy

  2014cited by this paper
• [Structure and functions of plasminogen/plasmin system].

  2014cited by this paper
• Challenges in elucidating the genetics of diabetic retinopathy.

  2014cited by this paper
• Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis

  2013influential reference
• PAI-1 -675 4G/5G Polymorphism in Association with Diabetes and Diabetic Complications Susceptibility: a Meta-Analysis Study

  2013influential reference
• Genome-wide association study in a Chinese population with diabetic retinopathy.

  2013cited by this paper
• Genetics in Diabetic Retinopathy: Current Concepts and New Insights

  2013cited by this paper
• The power of generalized odds ratio in assessing association in genetic studies with known mode of inheritance

  2012cited by this paper
• RISK FACTORS FOR PROLIFERATIVE DIABETIC RETINOPATHY IN A LATINO AMERICAN POPULATION

  2012influential reference
• Plasma Plasminogen Activator Inhibitor-1 Is Associated with End-Stage Proliferative Diabetic Retinopathy in the Northern Chinese Han Population

  2012influential reference
• Statistical Applications in Genetics and Molecular Biology The Generalized Odds Ratio as a Measure of Genetic Risk Effect in the Analysis and Meta-Analysis of Association Studies

  2011cited by this paper
• Investigating Hardy–Weinberg equilibrium in case–control or cohort studies or meta-analysis

  2011cited by this paper
• Genome-wide meta-analysis for severe diabetic retinopathy.

  2011cited by this paper
• PAI-1 antagonists: the promise and the peril.

  2011cited by this paper
• Genome-wide association study of diabetic retinopathy in a Taiwanese population.

  2011cited by this paper
• Identification of Diabetic Retinopathy Genes through a Genome-Wide Association Study among Mexican-Americans from Starr County, Texas

  2010cited by this paper
• The genetics of type 2 diabetes: what have we learned from GWAS?

  2010cited by this paper
• Diabetic retinopathy

  2010cited by this paper
• Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.

  2009cited by this paper
• XbaI GLUT1 Gene Polymorphism and the Risk of Type 2 Diabetes with Nephropathy

  2009cited by this paper
• Fibrinolysis: the key to new pathogenetic mechanisms.

  2008influential reference
• Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes.

  2007cited by this paper
• Genetic model testing and statistical power in population‐based association studies of quantitative traits

  2007cited by this paper
• Overview of epidemiologic studies of diabetic retinopathy.

  2007cited by this paper
• Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agent.

  2007cited by this paper
• SNPStats: a web tool for the analysis of association studies

  2006cited by this paper
• Genetics of diabetic retinopathy

  2006cited by this paper
• Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies

  2006cited by this paper
• Haploview: analysis and visualization of LD and haplotype maps

  2005cited by this paper
• Structure and function of the plasminogen/plasmin system

  2005cited by this paper
• The Fibrinolysis System: Regulation of Activity and Physiologic Functions of Its Main Components

  2004influential reference
• Coagulation and Fibrinolysis Parameters in Type 2 Diabetic Patients with and without Diabetic Vascular Complications

  2004cited by this paper
• The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).

  2003cited by this paper
• The Structure of Haplotype Blocks in the Human Genome

  2002cited by this paper
• [Diabetic retinopathy].

  2001cited by this paper
• Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice.

  2000influential reference
• Diabetic retinopathy.

  1998cited by this paper
• Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.

  1998cited by this paper
• Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.

  1995cited by this paper
• Polymorphisms of the Plasminogen Activator Inhibitor- 1 Gene in Type 1 and Type 2 Diabetes, and in Patients with Diabetic Retinopathy

  1994cited by this paper

• The Role of VEGFA in T2DM-Nephropathy: A Genetic Association Study and Meta-Analysis

  2025cites this paper
• Precision Medicine for Diabetic Retinopathy: Integrating Genetics, Biomarkers, Lifestyle, and AI

  2025cites this paper
• Heritable genetic Variability in ovarian Tumours: Exploring venous thromboembolism susceptibility and cancer prognosis in a Hospital-Based study.

  2025cites this paper
• Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies

  2024cites this paper
• Serpin Family E Member 1 Tag Single-Nucleotide Polymorphisms in Patients with Diabetic Nephropathy: An Association Study and Meta-Analysis Using a Genetic Model-Free Approach

  2021influential citation
• Possible association between haemostasis dysfunction and early onset of microvascular complications in patients with type 1 diabetes.

  2020influential citation
• CYP1A2 rs762551 and ADORA2A rs5760423 Polymorphisms in Patients with Blepharospasm

  2020cites this paper
• Association of plasminogen activator inhibitor-1 4G5G Polymorphism with risk of diabetic nephropathy and retinopathy: a systematic review and meta-analysis

  2020cites this paper
• A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse

  2019cites this paper
• Effect of integrin AV and B8 gene polymorphisms in patients with traumatic brain injury

  2019cites this paper
• Lack of Association of the rs11655081 ARSG Gene with Blepharospasm

  2019influential citation
• AQP4 tag SNPs in patients with intracerebral hemorrhage in Greek and Polish population.

  2019cites this paper
• BDNF rs6265 (Val66Met) Polymorphism as a Risk Factor for Blepharospasm

  2018cites this paper
• SLC2A1 Tag SNPs in Greek Patients with Diabetic Retinopathy and Nephropathy

  2017cites this paper